Your browser doesn't support javascript.
loading
Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues.
Ye, Wang-Yang; Lu, Hui-Ping; Li, Jian-Di; Chen, Gang; He, Rong-Quan; Wu, Hua-Yu; Zhou, Xian-Guo; Rong, Min-Hua; Yang, Li-Hua; He, Wei-Ying; Pang, Qiu-Yu; Pan, Shang-Ling; Pang, Yu-Yan; Dang, Yi-Wu.
Afiliación
  • Ye WY; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Lu HP; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Li JD; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Chen G; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • He RQ; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Wu HY; Department of Cell Biology and Genetics, School of Preclinical Medicine, Guangxi Medical University, Nanning, People's Republic of China.
  • Zhou XG; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
  • Rong MH; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
  • Yang LH; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • He WY; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Pang QY; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Pan SL; Department of Pathophysiology, School of Pre-clinical Medicine, Guangxi Medical University, Nanning, People's Republic of China.
  • Pang YY; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Dang YW; Department of Pathology and The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
Cancer Biother Radiopharm ; 38(10): 684-707, 2023 Dec.
Article en En | MEDLINE | ID: mdl-34619053
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Biother Radiopharm Asunto de la revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Biother Radiopharm Asunto de la revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article